retatrutide news recency 3 New Phase data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Retatrutide, an experimental weight-loss drug,

It is difficult to distinguish symptoms from FDA-approved and compounded products, Basina noted

If lean mass is dropping too fast, your protocol needs adjustingmore protein, more training, or a slower rate of loss

Eye problems Rapid improvement in blood sugar may temporarily worsen diabetic retinopathy, an eye condition related to type 1 and type 2 diabetes

Unlike men who may see testosterone suppression, women often experience disrupted menstrual cycles due to the caloric deficit and rapid body composition changes

Weekly dosage schedule Starting dose: 0.25 mg weekly for first 4 weeks Titration phase: 0.5 mg weekly for 4 weeks and then, if tolerated, 1 mg weekly for 4 weeks Maintenance dose for long-term weight management: 1.7 mg once weekly for 4 weeks and then, if tolerated, 2.4 mg once weekly (maximum dose) Dosing considerations If you do not tolerate dose escalation, consult with your healthcare provider and consider delaying the dose escalation for at least 4 weeks

doi: 10.1016/j.pharmthera.2006.11.007 55 MaljaeiMBBahreiniA